Around a thousand GSK workers in Wavre stand in for the jobs at risk as management and unions sit down together for the first time
The vaccine maker wants to cut up to 1,217 white-collar and management jobs in Wavre and Rixensart; unions point to almost half a billion euros in public support.
Around a thousand employees gathered at pharmaceutical company GSK in Wavre shortly before 9 a.m. on Tuesday, L'Avenir reported. They symbolically represented the number of jobs under threat. According to RTBF, blue-collar workers, white-collar staff and managers took part. The action preceded an extraordinary works council, the first meeting between management and staff representatives since GSK announced its restructuring plan in October. According to La Libre, around twenty people sat on each side of the table and the meeting was expected to last until about 3 p.m.
The company wants to cut up to 1,217 jobs: 482 white-collar staff and 735 managers, with blue-collar workers spared, La Libre writes. The jobs will go in Wavre, where vaccines are made, and at the Rixensart research site. GSK has 8,230 employees in Belgium, according to L'Avenir. La Libre reports that more than 600 jobs have already disappeared over the past two years and that several union sources link the cuts to GSK's pledge to President Trump to invest around 30 billion dollars in the US over five years.
The unions want to talk not only about layoffs but also about keeping and expanding activities in Belgium, according to L'Avenir. They point out that public authorities have put almost half a billion euros into GSK, and argue that public money cannot be used to support an industry and then to manage its disappearance. Little was known about the outcome of the works council by Tuesday evening.